ValueQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses28.18 M35.53 M49.84 M52.27 M21.72 M159.35 MResearch & development66.57 M76.24 M80.3 M90.46 M85.05 M332.06 MOperating income-94.75 M-111.41 M-129.11 M-142.59 M-133.67 M-516.77 MNon-Operating Income, Total14.15 M14.63 M13.47 M12.49 M11.03 M51.63 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses14.37 M14.63 M13.47 M12.54 M11.16 M51.81 MUnusual income/expense-218 K——-49 K-125 K—Pretax income-80.59 M-96.77 M-115.64 M-130.09 M-122.64 M-465.14 MEquity in earnings0——00—Taxes-6.57 M———180 K—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations-80.59 M-96.77 M-115.64 M-130.09 M-122.81 M-465.32 MDiscontinued operations——————Net income-80.59 M-96.77 M-115.64 M-130.09 M-122.81 M-465.32 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders-80.59 M-96.77 M-115.64 M-130.09 M-122.81 M-465.32 MBasic earnings per share (Basic EPS)-0.86-1.04-1.23-1.38-1.3-4.95Diluted earnings per share (Diluted EPS)-0.86-1.04-1.23-1.38-1.3-4.95Average basic shares outstanding80.78 M93.1 M93.79 M94.22 M94.06 M375.17 MDiluted shares outstanding80.78 M93.1 M93.79 M94.22 M94.06 M375.17 MEBITDA-98.91 M-115.78 M-133.83 M-146.19 M-19.3 M-415.09 MEBIT-94.75 M-111.41 M-129.11 M-142.59 M-16.56 M-399.66 MCost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)-4.16 M-4.38 M-4.71 M-3.6 M-2.73 M-15.43 M
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.